Today is the #MDSCongress early registration deadline. Register now to receive the best rates. mdscongress.org
International Parkinson and Movement Disorder Society
Non-profit Organization Management
Milwaukee, WI 8,377 followers
About us
MDS is a professional society of over 10,000 clinicians, scientists and other healthcare professionals dedicated to improving the care of patients with movement disorders through education and research. In recent years, there has been tremendous growth in new diagnostic information, pharmacological and neurosurgical treatments for Movement Disorders, as well as a greater understanding of impaired motor control function. MDS offers you and your patients an essential link to this knowledge. Visit the MDS website for more information: www.movementdisorders.org
- Website
-
http://www.movementdisorders.org
External link for International Parkinson and Movement Disorder Society
- Industry
- Non-profit Organization Management
- Company size
- 11-50 employees
- Headquarters
- Milwaukee, WI
- Type
- Nonprofit
- Founded
- 1985
- Specialties
- Research, Education, Scientific Journals, Membership, International Congress, and Rating Scales
Locations
-
Primary
Get directions
555 E. Wells Street
Suite 1100
Milwaukee, WI 53202-3823, US
Employees at International Parkinson and Movement Disorder Society
-
Shea Higgins
Asst. Director of Communications - International Parkinson and Movement Disorder Society
-
Jiri Mekyska
Principal Scientist in Digital Biomarkers | Director of the Brain Diseases Analysis Laboratory at BUT | Co-Founder and Chief Scientific Officer at…
-
Shannon Fraaza
Meetings Manager at Movement Disorder Society
-
MDS International Secretariat
This is the International Secretariat of MDS. Please join our LinkedIn Group & follow the company page for more updates.
Updates
-
The Presidential Lectures are a cornerstone of the #MDSCongress. Hear some of the field’s most esteemed honorees speak about the topics that have most interested them throughout their storied careers. Register today. mdscongress.org
-
-
A recent post-hoc analysis on prasinezumab investigated its potential effects on disease progression in various subpopulations of the PASADENA study. Dr. Gennaro Pagano dives into this exploratory analysis with the MDS Podcast. https://loom.ly/2Tvsp-M
-
-
Wilson's disease causes copper build-up in the body, which can be lowered with treatments like zinc salts. Monitoring of chronic treatments is essential because it could lead to copper deficiency, which can manifest as cytopenia and/or neurological symptoms. https://loom.ly/tp7wq2Y
-
Advancing PD care with a global focus: highlighting issues of genetics and PD challenges in Africa. https://loom.ly/LM6mKec
Advancing PD care with a global focus
movementdisorders.org
-
DBS is highly personalized to each patient, and the number of options continues to grow. Get up to date on the latest developments in this advanced course. https://loom.ly/YcjiGqo
-
-
Deadline soon for MDS Member Opportunity: Serve as Editor of the MDS Newsletter. Application deadline: July 15 https://loom.ly/mM8IRLE
Moving Along Editor Position
movementdisorders.org
-
Niemann-Pick type C1 disease (NPC1) is an autosomal recessive disorder with a heterogenous clinical presentation. The largest cohort study on NPC1 reports on a promising new biomarker for disease progression, PPCS. https://loom.ly/cOoqitE
At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years - PubMed
pubmed.ncbi.nlm.nih.gov
-
An international panel of neuroscientists discusses how measuring α-syn level using seed amplification assays has aided early detection of Parkinson’s. Future research will determine if SAA can reliably identify disease before onset of clinical symptoms. https://loom.ly/NpCGTUU
-
-
Dr. Ray Dorsey shares what the ‘End Parkinson’s Act’ means for Parkinson’s initiatives, especially concerning environmental factors, both in the USA and globally. https://loom.ly/5u_FG0c
End Parkinson’s Act
movementdisorders.org